Mary Lou Smith

ORCID: 0000-0002-1937-1026

Also affiliated with Hospital for Sick Children, SickKids Foundation, Research Advocacy Network

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Importance of Low- and Moderate-Grade Adverse Events in Patients' Treatment Experience and Treatment Discontinuation: An Analysis of the E1912 Trial”.

Importance of Low- and Moderate-Grade Adverse Events in Patients' Treatment Experience and Treatment Discontinuation: An Analysis of the E1912 Trial

Journal of Clinical Oncology(2023)10.1200/jco.23.00377

N/A

2.3DataRank · unranked

46 citations

Fengmin Zhao, Ju‐Whei Lee, Edward H. Ip, John Devin Peipert, Noah Graham +11 more

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update

Journal of Clinical Oncology(2020)10.1200/jco.20.01399

N/A

1.0DataRank · unranked

995 citations

Christina Lacchetti, Jonathan Bleeker, Guido Cavaletti, Cynthia Chauhan, Daniel L. Hertz +11 more

Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple Myeloma

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.3854

N/A

0.864DataRank · unranked

21 citations

Fengmin Zhao, Ju‐Whei Lee, Shu-en Shen, Edward H. Ip, Nathaniel S. O’Connell +12 more

Predictive value of baseline patient-rated treatment bother for early anastrozole discontinuation in a racially diverse cohort: Results from ECOG-ACRIN E1Z11.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12094

N/A

0DataRank · unranked

0 citations

John Devin Peipert, Vered Stearns, Victor T. Chang, Opeyemi A. Jegede, Edward H. Ip +15 more

Composite grading algorithm for National Cancer Institute’s PRO-CTCAE.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.7018

N/A

0DataRank · unranked

5 citations

Claus Becker, Lauren J. Rogak, Deborah Schrag, Bryce B. Reeve, Patricia A. Spears +15 more

A spotlight on avoidance coping to manage fear of recurrence among breast cancer survivors in an eHealth intervention

Journal of Behavioral Medicine(2022)10.1007/s10865-022-00349-8

N/A

0DataRank · unranked

12 citations

Beverly J. Levine, Elizabeth Jeter, Allison Chandler, Janet A. Tooze, Jenna Duffecy +10 more

Discerning the impact of ctDNA detection on patient decision-making in early-stage breast cancer

npj Breast Cancer(2024)10.1038/s41523-024-00701-y

N/A

0DataRank · unranked

2 citations

Mary Lou Smith, Elda Railey, Gregory D. Zimet, Bryan P. Schneider, Tarah J. Ballinger

Overall side‐effect bother consistently associated with early treatment discontinuation due to adverse events in four clinical trials with various cancer types and treatments

Cancer(2025)10.1002/cncr.70084

N/A

0DataRank · unranked

2 citations

Shaili Ganatra, Fengmin Zhao, Ju‐Whei Lee, Jessica Roydhouse, Edward H. Ip +13 more

Clinical implications of naming performance and seizure lateralization in bilingual children with epilepsy

Epilepsia(2025)10.1111/epi.18373

N/A

0DataRank · unranked

1 citations

Mary Lou Smith, William S. MacAllister, Nahal Heydari, Robyn M. Busch, Robert J. Fee +3 more